Neonatal Sepsis
Neonatal sepsis is a life-threatening infection in the first 28 days of life. NICE CG149 guides risk factor-based screening and empirical treatment with IV benzylpenicillin and gentamicin within 1 hour of suspicion.
Key Facts
Early-onset neonatal sepsis (EONS): <72 hours; most commonly Group B Streptococcus (GBS) and E. coli Late-onset neonatal sepsis (LONS): 72 hours to 28 days; CoNS (in preterm with central lines), S. aureus, Gram-negatives, Candida NICE CG149: Risk factor-based approach — red flags (antibiotics for maternal sepsis, confirmed GBS with risk factors, signs of neonatal sepsis) require immediate treatment Empirical treatment: IV benzylpenicillin 25mg/kg + gentamicin 5mg/kg — start within 1 hour Signs are non-specific: Temperature instability, poor feeding, lethargy, respiratory distress, apnoeas, tachycardia, irritability, abdominal distension GBS is the most common cause of EONS in the UK — incidence ~0.5 per 1000 live births; UK does NOT routinely screen pregnant women (unlike USA) LP should be performed in all neonates with confirmed sepsis or strong suspicion of meningitis unless contraindicated Blood culture is the gold standard — but may take 24-48h to grow; treat empirically while awaiting
Overview
Key Facts
Neonatal sepsis remains a significant cause of neonatal mortality and morbidity. The non-specific nature of neonatal sepsis signs makes a high index of suspicion essential. NICE CG149 provides a structured approach based on risk factors and clinical indicators.
Epidemiology
EONS incidence: ~0.9 per 1,000 live births. GBS-EONS: ~0.5 per 1,000. LONS is more common in preterm infants, especially those with central venous lines. Neonatal sepsis mortality: ~5-10% for term infants, up to ~30% for very preterm.
Aetiology
Early-onset (<72h):
- Group B Streptococcus (GBS) — most common overall
- Escherichia coli — most common Gram-negative; leading cause in preterm EONS
- Listeria monocytogenes — uncommon but important (maternal food-borne)
Late-onset (72h-28 days):
- Coagulase-negative Staphylococci (CoNS) — most common in NICU (line-related)
- Staphylococcus aureus, E. coli, Klebsiella, Candida (very preterm)
Pathophysiology
Neonatal immune system is immature: reduced complement activity, low IgM and IgA (only maternal IgG crosses placenta), impaired neutrophil chemotaxis and opsonisation, and reduced T-cell function. This renders neonates highly susceptible to bacterial infection with rapid progression to septic shock and meningitis.
Clinical Presentation
Clinical Signs (Non-Specific)
- Temperature: Hypothermia (<36°C) or fever (>38°C); hypothermia more common in preterm
- Respiratory: Tachypnoea, grunting, apnoeas, increased O2 requirement
- Cardiovascular: Tachycardia, poor perfusion, hypotension (late sign)
- Neurological: Lethargy, irritability, poor feeding, seizures, bulging fontanelle
- GI: Feeding intolerance, abdominal distension, vomiting
- Skin: Mottling, pallor, petechiae, prolonged CRT
NICE CG149 Risk Factors for EONS
Red flags (treat immediately):
- Clinical signs of neonatal sepsis
- Suspected or confirmed maternal sepsis treated with IV antibiotics
- Maternal GBS colonisation + ONE of: preterm labour, PROM >18h, maternal fever >38°C
Non-red flag risk factors (observe ± treat):
- PROM >18h, maternal GBS colonisation (without additional risk factors), maternal pyrexia, gestational age <37 weeks
Red Flags
- Apnoeas — may be only sign of sepsis in preterm infants
- Seizures — suggests meningitis
- Rapidly deteriorating — fulminant sepsis/meningitis
- Purpura/petechiae — DIC, meningococcal (rare in neonates)
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| Neonatal sepsis | Risk factors + non-specific signs | Blood culture, FBC, CRP |
| Respiratory distress syndrome | Preterm, ground glass CXR, surfactant deficiency | CXR, blood gas |
| Congenital pneumonia | Prolonged rupture of membranes, respiratory distress | CXR, blood culture |
| Congenital heart disease | Cyanosis, murmur, poor feeding | Echocardiography |
| Metabolic disease | Lethargy, poor feeding, metabolic acidosis | Blood gas, ammonia, amino acids |
| Necrotising enterocolitis | Abdominal distension, bloody stools, pneumatosis | AXR |
Diagnosis / Investigation
Bedside
- Observations: Temperature, HR, RR, SpO2, BP, capillary refill
- Blood glucose: Hypoglycaemia common in sepsis
Bloods
- Blood culture: GOLD STANDARD — before antibiotics if possible (but do NOT delay antibiotics)
- FBC: WCC may be high, low, or normal; left shift (raised immature:total neutrophil ratio); thrombocytopenia
- CRP: May be normal initially; repeat at 18-24h (serial CRP is useful)
- Procalcitonin: Rising — more specific than CRP for bacterial infection
- Blood gas: Metabolic acidosis in severe sepsis
Imaging
- CXR: If respiratory symptoms — pneumonia, RDS
- AXR: If abdominal signs — NEC
Special Tests
- LP (CSF): For all confirmed sepsis or strong clinical suspicion of meningitis — cell count, protein, glucose, culture, PCR
- Urine MC&S: More relevant in LONS (clean catch or SPA)
- Surface swabs: Ear, umbilicus — may guide therapy but not diagnostic of invasive infection
Management
Pharmacological
EONS (<72h):
- IV benzylpenicillin 25mg/kg 12-hourly (term; 8-hourly if meningitis) + gentamicin 5mg/kg OD
- Start within 1 hour of decision to treat
- Duration: Stop at 36-48h if blood culture negative AND clinically well AND CRP not rising
- If culture positive or meningitis confirmed: Continue for 7-14 days (meningitis: 14-21 days depending on organism)
LONS (>72h):
- Flucloxacillin + gentamicin (or per local protocol if NICU-acquired — may need broader cover)
- Candida: Fluconazole or amphotericin B for very preterm infants
Meningitis:
- Extend to meningitis doses: Benzylpenicillin or cefotaxime 50mg/kg + gentamicin
- Duration: GBS meningitis 14 days; Gram-negative meningitis 21 days
Non-pharmacological
- IV access: Ensure reliable venous access
- Fluid resuscitation: 10-20mL/kg 0.9% NaCl bolus if signs of shock; may need inotropes
- Respiratory support: CPAP, IPPV as needed
- Monitoring: Continuous cardiorespiratory monitoring, fluid balance, blood glucose
- Nutritional support: May need parenteral nutrition if feeds withheld
Referral Criteria
- All unwell neonates — neonatal team assessment
- Meningitis — neonatal unit; may need neurosurgical input if complications
- Not responding to first-line antibiotics — microbiology/infectious disease input
- Preterm LONS — neonatal unit
Prognosis
- EONS (GBS) mortality: ~5-10% in term infants; higher in preterm
- Gram-negative EONS mortality: ~15-20%
- GBS meningitis: Mortality ~10%; long-term neurodevelopmental sequelae in ~50% of survivors
- LONS (CoNS): Low mortality (<5%) but associated with prolonged NICU stay
- CRP as guide: Serial CRP helps guide antibiotic duration; falling CRP supports stopping at 36-48h if culture negative
Other Relevant Information
NICE CG149 — Decision Framework
| Scenario | Action |
|---|---|
| Clinical signs of sepsis | Blood culture + antibiotics within 1h |
| Maternal IV antibiotics for sepsis | Blood culture + antibiotics within 1h |
| GBS + 1 risk factor | Blood culture + antibiotics within 1h |
| PROM >18h alone | Observe + check CRP at 12h (enhanced observation) |
| GBS alone (no other risk factors) | Enhanced observation for 12h |
Antibiotic Doses (Neonatal)
| Drug | Dose (term) | Frequency |
|---|---|---|
| Benzylpenicillin | 25mg/kg | 12-hourly (<7d); 6-hourly (>7d or meningitis) |
| Gentamicin | 5mg/kg | Once daily (adjust per levels) |
| Cefotaxime | 50mg/kg | 8-12 hourly |
| Flucloxacillin | 25-50mg/kg | 6-12 hourly |